Innoviva (INVA)

• Market cap: $1.65B
• 1 day: -1.41%
• 5 days: -0.49%
• 1 month: 2.05%
• 3 months: 1.22%
• 6 months: 11.32%
• Year to date: 12.83%
• 1 year: 2.84%
• 5 years: 76.4%
• 10 years: 100.9%
• Sector: Healthcare
• Industry: Biotechnology

About: Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.

Employees: 159